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Changes in Gab2 phosphorylation 
and interaction partners in 
response to interleukin (IL)-2 
stimulation in T-lymphocytes
Nerea Osinalde†, Virginia Sánchez-Quiles‡, Blagoy Blagoev & Irina Kratchmarova
Interleukin-2 (IL-2) stimulation results in T-cell growth as a consequence of activation of highly 
sophisticated and fine-tuned signaling pathways. Despite lacking intrinsic enzymatic activity, 
scaffold proteins such as Gab2, play a pivotal role in IL-2-triggered signal transduction integrating, 
diversifying and amplifying the signal by serving as a platform for the assembly of effectors proteins. 
Traditionally, Gab2-mediated protein recruitment was believed to solely depend on cytokine-induced 
phosphotyrosine moieties. At present, phosphorylation on serine/threonine residues is also emerging as 
a key mediator of Gab2-dependent signal regulation. Despite its relevance, IL-2-triggered regulation on 
Gab2 phosphorylation is yet poorly understood. Combining antibody- and TiO2-based enrichment of the 
scaffold protein with SILAC quantitative mass spectrometry we disclose the prominent regulation IL-2 
exerts on Gab2 serine/threonine phosphorylation by showing that at least 18 serines and 1 threonine, 
including previously non-reported ones, become phosphorylated in response to cytokine stimulation. 
Additionally, we decipher the interactome of the docking protein in resting and cytokine-treated 
T-lymphocytes and besides well-known Gab2 interactors we discover three novel cytokine-inducible 
Gab2-binding proteins. Thus, our data provide novel insights and a wealth of candidates for future 
studies that will shed light into the role of Gab2 in IL-2-initiated signal transduction.
Interleukin 2 (IL-2) is a pleiotropic cytokine that promotes differentiation of naive CD4+ and CD8+ 
T-lymphocytes into effector and memory T-cells respectively, augments the cytolytic activity of CD8+ T-cells 
and natural killer cells (NK-cells), triggers activation-induced cell death (AICD) and stimulates proliferation of 
different immune cell types1–4. Indeed, due to its capacity to promote T-cell growth, IL-2 has clinically emerged as 
the most widely used cytokine in adoptive immunotherapy for cancer5–6. Despite its effectiveness, IL-2 treatment 
is often accompanied by undesired side effects that must be overcome in order to ensure safer therapies. Hence, 
the characterization of the molecular events underlying IL-2-dependent responses constitutes a key way into the 
development of more accurate treatments.
Binding of IL-2 to its transmembrane receptor (IL-2R) results in the rapid activation of highly interconnected 
and carefully orchestrated signaling pathways that ultimately converge into the nucleus eventually elaborating the 
desired cellular output7–8. The initial step in IL-2 signaling involves activation of JAK tyrosine kinases which phos-
phorylate the receptor, thus creating anchoring sites for signal relay molecules bearing phosphotyrosine-binding 
(PTB) and Src-homology 2 (SH2) domains that are subsequently phosphorylated as well9–10. Hence, the binding 
of the cytokine to the cell surface promotes the formation of large intracellular molecular complexes that allow a 
fast and amplified propagation of the signal. Among the recruited proteins, several of them constitute enzymes 
or transcription factors whose activity is indeed regulated by site-specific modifications11–12. Additionally, some 
of the molecular characters associated to the activated receptors represent scaffold or docking proteins with 
no inherent enzymatic or transcriptional activity, but importantly serving as physical platforms facilitating the 
assembly of the signalling hubs. Scaffold molecules thereby enable the localization of other effector proteins at 
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specific cellular compartments, protect them from inactivation and integrate positive and negative feedback 
mechanisms, ultimately allowing the modulation of the signal transduction13.
Among the scaffold proteins involved in the signaling transduction triggered by IL-2 stands the human 
Grb2-associate binder (Gab) family, which is comprised by three members (Gab1–3). Upon stimulation Gab pro-
teins become phosphorylated and act as molecular bridges between growth factor- or cytokine-activated receptor 
complexes and downstream signaling molecules14–16. In fact, among others we have demonstrated that docking 
proteins Gab2 and Gab3 become tyrosine phosphorylated and hence, participate in the signaling networks initi-
ated by IL-2 in CD4+ T-lymphocytes17–21. Upon stimulation, phosphotyrosine moieties mediate the interaction 
with diverse signaling molecules, such as, PTPN11, p85 regulatory subunit of PI-3 kinase, PLCγ , Shc and CrkL 
which leads to the activation of RAS/MAPK and PI3K/AKT signaling pathways22. Indeed, Gab2 overexpression 
has been shown to promote the alteration of these signaling branches, importantly contributing to the develop-
ment of distinct cancers including breast and ovarian cancer, leukemia and melanoma23–25.
At present, serine and threonine phosphorylations of Gabs are emerging as key regulatory mechanism that 
can determine the fate of the signal. Lynch and co-workers first demonstrated that AKT-mediated phosphoryl-
ation on Gab2 S159 contributes to the attenuation of heregulin (HRG)-activated signaling pathways by uncou-
pling Gab2 from ErbB receptors26. Similarly, growth factor-triggered phosphorylation on Gab2 S210 and T391 
has been shown to mediate negative feedback regulation by recruiting 14–3–3 proteins that disrupt Gab2/Grb2 
interaction27. The biological significance of such finding became clear with the recent discovery that Gab1 T387, 
corresponding to Gab2 T391, is mutated (T387N) in breast cancer which results in EGF-independent prolifera-
tion of mammary epithelial cells as a consequence of impaired signal attenuation mechanism28. Consequently, the 
biological relevance of Gab2 phosphorylation occurring not only on tyrosines but also on serine and threonine 
residues is indisputable.
Biochemical analyses have already suggested that Gab2 is highly phosphorylated on serine and threonine 
residues in response to IL-217. However, the precise effect that IL-2 exerts on the distinct site-specific phospho-
rylable residues on the scaffold proteins remains elusive. Here, we present the largest phosphoproteomic study 
depicting Gab2 phosphorylations in resting and IL-2-treated CD4+ T-lymphocytes. We identify 29 distinct phos-
phorylations on human Gab2 including 3 novel phosphorylated serine residues (pS146, pS147 and pS459) that 
have never been reported before. More importantly, we provide robust quantification data regarding 24 phospho-
rylation sites and provide evidence indicating that IL-2 triggers at least the phosphorylation of 18 serines and 1 
threonine. Additionally, considering that the role of Gab2 consists on serving as a molecular platform to recruit 
distinct signaling proteins, we dissected the Gab2 interactome in resting and cytokine-treated T-lymphocytes by 
taking advantage of Stable Isotope Labeling by Amino acids in Cell culture (SILAC) quantitative mass spectrom-
etry (Q-MS)29–32. Besides detecting already reported cytokine-dependent and – independent Gab2 interactors, 
we discovered 3 previously unknown cytokine-inducible Gab2-binding proteins which were further validated 
by Western blotting. Collectively, the data provided here considerably expand the current knowledge of the 
IL-2-dependent regulation of Gab2 which may originate a plethora of future investigations shedding new light 
into the role of the scaffold proteins in the signaling networks initiated by IL-2.
Results
Kit225 T-lymphocytes express Gab2 and Gab3 but not Gab1. Our previous studies deciphering the 
tyrosine-phosphoproteome of IL-2 pathways demonstrated that Gab2 and Gab3 participate in the signal trans-
duction initiated by the cytokine in Kit225 T-lymphocytes20–21. Gab1, in turn, has never been identified in those 
experiments, which does not necessarily imply that is not expressed in Kit225 T-cells. For that reason, in order to 
determine which Gab family members are expressed in this CD4+ T-cell line, mRNA levels of each gene-product 
were measured by real time quantitative PCR. As shown in Fig. 1A, mRNA levels of Gab2 and Gab3 were high 
in Kit225 T-cells, whereas Gab1 gene expression was nearly undetectable. On the contrary, HeLa cells expressed 
high levels of Gab1 but low or almost undetectable amounts of Gab2 and Gab3, which is in agreement with 
recently published data33. In line with that, Western blot analyses revealed that expression of Gab1 and Gab2 is 
restricted to HeLa and Kit225 T-cell, respectively (Fig. 1B). Antibody-based detection of Gab3 was not successful 
but our previous mass spectrometry-based works have repeatedly demonstrated that Gab3 is also expressed in 
Figure 1. Expression of Gab family members. (A) Gab1-3 gene expression was determined in HeLa and 
Kit225 cells using quantitative RT-PCR. (B) Gab1-2 protein levels were detected in HeLa and Kit225 T-cells by 
Western blot.
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Kit225 T-lymphocytes20–21. Altogether, our data indicate that Gab2 and Gab3 are the only Gab family members 
predominantly expressed in Kit225 T-cells and hence, participating in IL-2 signal transduction.
SILAC-based quantitative phosphoproteomics/proteomics approach to characterize 
IL-2-triggered regulation of Gab2. Gab2 and Gab3 family members share moderate sequence homology 
(33.4% identity) but they conserve the same modular structure16 (Supplementary Fig. S1). Therefore, it seems 
plausible that IL-2-triggered regulation of both scaffold proteins does not differ so much. Nonetheless, Gab2 is 
larger than Gab3 and contains more protein binding regions which may explain why Gab2-deficient mice show 
more defects that Gab3-deficient ones34–36. For that reason, we decided to focus our investigation on studying in 
detail IL-2-mediated modulation of Gab2 as the representative Gab family member expressed in Kit225 T-cells.
To depict Gab2 site-specific phosphorylation events and unveil the cytokine-dependent and –independent 
interactors of the scaffold protein we followed the experimental design outlined in Fig. 2A. Two populations of 
Kit225 T-cells were cultured in “light” or “heavy” media and were kept unstimulated (Ctr) or were stimulated for 
5 minutes with IL-2, respectively. After cell lysis, samples were equally mixed, subjected to immunoprecipitation 
using an antibody against Gab2 and eluted immune complexes were fractionated by SDS-PAGE followed by in-gel 
digestion. Part of the sample was desalted and directly analyzed by LC-MS/MS aiming to detect Gab2-interacting 
partners whereas the remaining part was enriched in phosphopeptides using TiO2 beads prior to MS analysis. In 
addition to detect site-specific phosphorylations and putative Gab2 interactors, the use of SILAC allows discern-
ing between IL-2-dependent and -independent phosphorylation events as well as constitutive and IL-2-inducible 
Gab2 interactors. A phosphopeptide bearing a site-specific phosphorylation that is not affected by IL-2 stimu-
lation will be similarly enriched in resting and cytokine-treated cells, thus it will display a SILAC IL-2/Ctr ratio 
of 1 (Fig. 2B, left MS spectra). Likewise, peptides derived from a protein that is constitutively associated with the 
scaffold protein will also show a SILAC ratio of 1. On the contrary, if IL-2 induces phosphorylation on a specific 
Figure 2. Experimental workflow followed to dissect IL-2-triggered regulation on Gab2. (A) A schematic 
flow diagram depicting the steps for identification and quantification of Gab2 phosphopeptides as well as Gab2-
interacting proteins. (B) Examples of SILAC MS spectra illustrating peptides that display different ratios. The 
left peptide shows no regulation by IL-2 (IL-2/Ctr ratio = 1) whereas the right peptide shows upregulation upon 
IL-2 stimulation (IL-2/Ctr ratio > 1.5 for interacting proteins and IL-2/Ctr ratio > 2 for phosphopeptides). 
Peptides derived from resting T-cells are marked in grey whereas the ones derived from IL-2-treated condition 
are marked in pink.
www.nature.com/scientificreports/
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residue or promotes an interaction between Gab2 and a signaling protein, the corresponding phosphopeptide 
and peptides respectively, will be more abundant in the cytokine-treated condition (Fig. 2B, right MS spectra).
Depicting Gab2 phosphorylation in resting and IL-2-treated T-lymphocytes. Following the 
approach described above, we confidently identified 29 amino acids on Gab2 that are phosphorylated in vivo 
including 22 phosphorylated serines (pS), 5 phosphorylated threonines (pT) and 2 phosphorylated tyrosines 
(pY). Interestingly, 6 of these Gab2 pS (pS133, pS148, pS149, pS223, pS281, pS422) are conserved in the Gab 
family member Gab3 (corresponding to pS132, pS141, pS142, pS209, pS242, pS362, respectively) that is also 
expressed in Kit225 T-lymphocytes (Table 1). In addition, the phosphorylated Gab2 residues S141, T319 and 
T391 align with distinct but still phosphorylable Gab3 residues (T134, S273 and S344, respectively). In fact, we 
have already demonstrated that Gab3 S344 and S362 are phosphorylated in IL-2-treated CD4+ T-lymphocytes20. 
Altogether, it seems plausible that the putative and confirmed Gab3 phosphosites mentioned above are subjected 
to similar regulation as Gab2 in Kit225 T-cells upon cytokine treatment.
It is worth highlighting that this is the first study demonstrating that Gab2 S147 and S459 can be phospho-
rylated in human CD4+ T-lymphocytes. Moreover, this study provides unprecedented evidence indicating that 
human Gab2 S146 can also be phosphorylated, a residue that was already reported to be modified in mice37. The 
precise assignment of those phosphorylation sites was verified by manual annotation of their corresponding frag-
mentation spectra. As shown in Fig. 3A, the presence of the 984.58+1 ion (y9** in SpSPAELpS146SpSSQHLLR) 
and the absence of the 1093.4534+1 ion (y8 in SpSPAELSpS147pSSQHLLR) supports the unambiguous identifica-
tion of the phosphorylation of S146 residue in Gab2. Similarly, the presence of the 915.51+1 and 846.488+1 ions 
(y8* and y7 in SpSPAELSpS147SSQHLLR) and the absence of the ion 915.51+1 (y7 in SpSPAELSSpS148SQHLLR or 
SpSPAELSSSpS149QHLLR) allows to assign the position of the phosphosite to S147 of Gab2 (Fig. 3B). Regarding 
the Gab2 phosphopeptide comprising amino acid residues 443–467, the discriminating ions y8 and y9* indicate 
that among the six phosphorylable residues within the Gab2 phosphopeptide 443–467, only S459 is phosphoryl-
ated (Fig. 3C).
Gab2 is known to be tyrosine phosphorylated in response to IL-2 and accordingly we found that Y476 and 
Y643 become phosphorylated in cytokine-treated CD4+ T-lymphocytes (Supplementary Fig. S2). More interest-
ingly, the study presented here identified a large number of Gab2 pS/pT residues that are differentially regulated 
in response to IL-2 stimulation (Table 1). Our SILAC-based quantitative phosphoproteomic screen shows that 
Modified  
Gab2 site Modified sequence PEP Score Charge m/z
Replica 1 Replica 2
Conserved 
in Gab3IL-2/Ctr 
ratio
Peak Intensity IL-2/Ctr 
ratio
Peak Intensity
Ctr IL-2 Ctr IL-2
S133 NVSpSAGHGPR 3.9E-03 123.92 2 531.23 27.0 3.1E+ 06 8.6E+ 07 – – – S132*
S141 SpSPAELSSSSQHLLR 3.9E-98 253.73 2 839.89 9.0 1.1E+ 09 2.5E+ 09 3.5 1.5E+ 09 2.5E+ 09 T134*
S146* SpSPAELpSSpSSQHLLR 1.8E-02 61.181 2 919.86 – – – – – – no
S147* SpSPAELSpSSSQHLLR 8.0E-48 183.56 2 879.88 – – 2.7E+ 07 31.1 4.2E+ 05 1.7E+ 07 no
S148 pSSPAELSSpSSQHLLR 3.9E-98 259.18 2 879.88 7.0 3.0E+ 07 8.6E+ 08 2.8 4.3E+ 07 6.5E+ 08 S141*
S149 SpSPAELSSpSpSQHLLR 1.0E-72 259.18 2 919.86 – – 1.0E+ 06 – – 2.1E+ 06 S142*
S210 SApSFSQGTR 9.6E-05 183.99 2 510.71 2.0 4.3E+ 09 6.7E+ 09 1.9 1.6E+ 09 2.3E+ 09 no
S223 ASFLoxMRpSDTAVQK 7.9E-21 184.37 2 775.36 8.1 6.2E+ 08 1.2E+ 09 2.2 6.4E+ 08 7.3E+ 08 S209*
S264 HNTEFRDpSTYDLPR 5.9E-84 269.71 3 610.93 4.3 4.5E+ 08 1.7E+ 09 9.9 7.9E+ 07 3.1E+ 08 no
T265 HNTEFRDSpTYDLPR 2.9E-02 89.353 2 915.89 – – – – – – no
S281 GpSLTGSETDNEDVYTFK 5.8E-77 256.11 2 971.90 – – 3.7E+ 07 3.8 2.9E+ 06 3.2E+ 07 S242*
S285 GSLTGpSETDNEDVYTFK 2.4E-52 298.22 2 971.90 3.4 5.9E+ 07 4.4E+ 08 3.9 4.5E+ 07 2.8E+ 08 no
T287 GSLTGSEpTDNEDVYTFK 6.3E-83 375.45 2 971.90 0.5 3.1E+ 08 2.1E+ 08 0.6 2.0E+ 08 1.3E+ 08 no
T319 EFGDLLVDNoxMDVPApTPLSAYQIPR 6.7E-29 184 2 1379.15 7.9 9.9E+ 06 3.2E+ 08 18.8 1.9E+ 06 9.2E+ 07 S273*
S322 EFGDLLVDNoxMDVPATPLpSAYQIPR 1.5E-20 170.27 3 919.77 9.1 3.2E+ 06 8.5E+ 07 10.3 1.7E+ 06 6.3E+ 07 no
S368 WGpSPQQRPPISENSR 2.3E-02 68.567 3 606.95 2.3 4.3E+ 08 2.7E+ 08 – – – no
T385 SVAApTIPRR 1.2E-04 128.01 2 525.78 0.5 3.0E+ 08 1.0E+ 08 1.1 1.2E+ 08 4.2E+ 07 no
T391 RNpTLPAMDNSR 1.2E-13 265.64 3 452.20 1.5 1.5E+ 09 2.8E+ 09 1.3 3.8E+ 08 4.0E+ 08 S344
S404 LHRApSSCETYEYPQR 3.8E-06 141.6 3 659.62 13.8 7.9E+ 05 3.1E+ 07 5.1 2.2E+ 05 1.9E+ 06 no
S405 ASpSCETYEYPQR 6.0E-07 137.81 2 785.80 8.0 1.1E+ 07 9.9E+ 07 2.0 4.7E+ 07 4.7E+ 07 no
S422 pSAESoxMSDGVGSFLPGK 1.3E-44 210.75 2 832.85 8.3 4.4E+ 06 3.4E+ 07 5.0 3.4E+ 07 6.3E+ 07 S362
S425 SAEpSMSDGVGSFLPGK 9.7E-45 221.79 2 824.85 5.9 4.4E+ 07 1.8E+ 08 7.1 1.6E+ 07 1.1E+ 08 no
S459* SDSTNSEDNYVPoxMNPGpSSTLLAoxMER 2.7E-12 143.07 2 1414.08 14.5 3.1E+ 06 1.6E+ 08 7.5 2.9E+ 06 1.1E+ 08 no
S480 AGDNSQSVYIPoxMpSPGAHHFDSLGYPSTTLPVHR 1.3E-57 197 4 909.42 2.2 5.7E+ 08 1.7E+ 09 2.2 5.6E+ 08 1.1E+ 09 no
S543 NNTVIDELPFKpSPITK 1.0E-210 350.82 2 948.48 8.7 5.0E+ 08 5.1E+ 09 4.9 4.8E+ 08 2.0E+ 09 no
Table 1.  Gab2 serine/threonine phosphorylations. In bold are phosphorylations induced by IL-2 whereas 
IL-2-independent phosphorylations are in italics. *indicates that the phosphorylated site is not reported in 
PhosphoSitePlus database.
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phosphorylations on Gab2 S210, T287, T385 and T391 are not affected (0.5 < IL-2/Ctr ratio < 2, in both repli-
cas) by cytokine stimulation. On the contrary, we provide evidence indicating that 18 serines and 1 threonine 
(T319) distributed along the central 400 amino acid-region of Gab2 (aa 141–543) become phosphorylated in 
vivo in CD4+ T-lymphocytes treated with IL-2. It should be noted that Gab2 pS147, pS149 and pS281 do not 
display a SILAC ratio in both replicas but still according to peak intensity data collected, the three phosphosites 
are induced in response to IL-2 treatment. As shown in Fig. 4, the three phosphosites are barely detectable in the 
light-labeled peak of the SILAC pair corresponding to resting T-cells (no intensity value). On the contrary, all of 
them were detected in the heavy-labeled SILAC condition corresponding to cytokine-treated T-lymphocytes and 
thus display a signal intensity which indicates that the three residues are phosphorylated upon IL-2 stimulation 
(Fig. 4A–C).
Overall, results presented here represent the largest dataset of IL-2-dependent and-independent Gab2 phos-
phorylations reported to date. Hence, our study adds to a growing body of literature that points towards phos-
phorylations occurring on serine and threonine residues as key players in the signaling pathways modulated by 
Gab2. Future investigation will be necessary to clarify the role of each site-specific phosphorylation in the signal 
transduction initiated by IL-2.
Figure 3. MS/MS spectra of novel Gab2 phosphopeptides identified. Annotated MS/MS spectrum of a  
(A) triply phosphoryated Gab2 peptide (SpSPAELpSSpSSQHLLR) containing pS146, (B) doubly phosporylated 
Gab2 peptide (SpSPAELSpSSSSQHLLR) containing pS147 and (C) singly phosphorylated Gab2 peptide 
(SDSTNSEDNYVPoxMNPGpSSTLLAMER) bearing pS459. The b ions (in blue) and y ions (in red) identified 
are indicated both in the spectrum and in the peptide sequence * or ** denotes loss of one or two H3PO4 (Δm 
97.9768) respectively, from the phosphorylated ion.
www.nature.com/scientificreports/
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Dissecting the interactome of Gab2 in IL-2-treated T-lymphocytes. Phosphorylations on Gab2 
serve as docking sites for downstream molecules that participate in the distinct signaling branches activated upon 
engagement of IL-2 and IL-2 receptor. In order to identify the proteins that are recruited to Gab2 in response 
to IL-2 stimulation, we combined immunoprecipitation of the endogenous scaffold protein with SILAC-based 
quantitative mass spectrometry as illustrated in Fig. 2A.
We quantified 709 and 714 proteins in the first and second replica performed respectively, of which 646 were 
commonly quantified in the two experiments (Fig. 5A & Supplementary Table S2). Comparison of the SILAC 
ratios obtained for those proteins showed strong correlation between the two biological replicas with Pearson 
coefficient of 0.9 (Fig. 5B). The majority of the proteins were found equally enriched in resting and IL-2-treated 
T-lymphocytes. These dataset embrace constitutive Gab2-binding proteins as well as unspecific interactors 
(Fig. 5C). It should be noted that among IL-2-independent Gab2-interacting proteins we detected the adaptor 
protein Grb2 (Supplementary Table S2). The constitutive association between the two proteins was further vali-
dated by Gab2 immunoprecipitation followed by Western blotting (Supplementary Fig. S3). These results indicate 
that the scaffold protein Gab2 and the adaptor protein Grb2 form a stable complex in CD4+ T-lymphocytes, 
which is line with previously published data38.
More interestingly, our interactome analysis revealed 9 proteins that were significantly enriched in 
Gab2-containing immune complexes upon cytokine stimulation (IL-2/Ctr > 1.5; Significance B p-value < 0.0001) 
indicating that their association with Gab2 depends on IL-2 treatment (Fig. 5C & Supplementary Table S2). 
The 9 inducible Gab2-interacting proteins detected displayed consistent SILAC ratio in the two biological repli-
cas performed (Fig. 6A). Tyrosine phosphatase PTPN11 and p85 PI3-kinase regulatory subunits alpha and beta 
(PIK3R1 and PIK3R2, respectively) were the IL-2-inducible Gab2 interactors showing the highest SILAC ratio. 
We validated these results by Western blot analyses which agree with previous studies showing that PTPN11 and 
p85 PI3-kinase interact with the tyrosine phosphorylated version of Gab239–41. Additionally, all catalytic subu-
nits comprising the Class IA of PI3K family were also found to be enriched in IL-2 treated conditions (PIK3CA, 
PIK3CB and PIK3CD). More interestingly, for the first time this study provides evidence that DLAT (a subunit 
of the pyruvate dehydrogenase complex) and transcription factors ARID3A and ARID3B associate with Gab2 in 
response to IL-2 stimulation. We could further confirm by immunoblotting that the three novel Gab2 interactors 
discovered in this study, named DLAT, ARID3A and ARID3B, indeed interact with Gab2 scaffold protein in 
IL-2-stimulated Kit225 T-lymphocytes (Fig. 6B).
The biological information extracted from the SILAC ratios obtained in the Gab2 immunoprecipitation exper-
iments is unquestionable as they allow recognizing the specific cytokine-dependent interactors of the scaffold 
protein from a dataset composed by hundreds of proteins. Nonetheless, protein SILAC ratios do not provide 
information on the relative abundance of the proteins within the complex. This however can be extracted from 
the peptide intensity information in the dataset since it is assumed that the signal response of the three most 
abundant peptides can provide good approximation of the amount of protein42. Accordingly, we calculated the 
relative abundance of each IL-2-dependent Gab2 interactor detected in this study (Fig. 6C). Our data indicate that 
the most prominent proteins associating with Gab2 are PTPN11 and PIK3R1, indeed the two well-documented 
Figure 4. MS spectra of IL-2-induced Gab2 phosphopeptides not displaying a SILAC ratio. MS spectra of 
(A) pS147-, (B) pS149- and (C) pS281-bearing phosphopeptides displaying no SILAC ratio. Whereas the light 
version of the phosphopeptide corresponding to resting T-cells (grey dot) is barely detectable, the heavy version 
of the same peptide (pink dot) is clearly distinguished indicating that upon cytokine stimulation Gab2 S147, 
S149 and S281 become phosphorylated.
www.nature.com/scientificreports/
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interactors of the scaffold protein. Strikingly, the binding level of ARID3B, the newly identified interactor of 
Gab2, was also found to be among the highest. The catalytic subunits of PI3-kinase family were detected lower in 
abundance as well as the novel interactors ARID3A and DLAT.
Discussion
IL-2-triggered signaling pathways are strictly fine-tuned by tyrosine phosphorylation events that trigger and 
modulate a wide range of processes such as protein-protein interaction, protein localization and enzymatic activ-
ity of distinct signaling molecules18–20,43. Initial events following cytokine and receptor engagement involve acti-
vation of JAK tyrosine kinases which in turn phosphorylate the receptor creating docking sites for signaling 
molecules that participate in transducing the signal initiated on the cell surface inside the cell. In response to 
cytokine stimulation, among others, Gab scaffold proteins are recruited to the activated receptor-complex where 
they become tyrosine phosphorylated and recruit additional effector molecules thereby integrating, amplifying 
and diversifying the signal transduction pathways44–45.
The initially discovered Gab family member Gab1 is believed to be ubiquitously expressed15,46; however, here 
we demonstrate that Gab1 mRNA and protein levels are barely detectable in Kit225 T-cells. On the contrary, Gab2 
and Gab3 are highly expressed in Kit225 CD4+ T-lymphocytes (Fig. 1). Indeed, we had previously demonstrated 
that Gab2 and Gab3 are tyrosine phosphorylated in response to IL-2 stimulation20–21. Altogether, our studies 
provide evidence indicating that the latter two Gab family members are the only ones participating in the signal 
transduction initiated by IL-2 in Kit225 T-lymphocytes.
Gab proteins can be recruited to the activated receptors through distinct mechanisms but according to the 
accumulated knowledge, the only mode for receptor interaction for Gab2 is indirectly via Grb216. Grb2 is a small 
adaptor protein composed by a Src homology 2 (SH2) domain that allows association with phosphorylated tyros-
ine resides, flanked by two SH3 domains that recognize proline-rich motifs47. Depending on the cellular sys-
tem Grb2/Gab2 complex has been found to be either constitutive or inducible. Whereas IL-3 stimulation of the 
murine pro-B-cell line Ba/F3 results in a significantly enhanced interaction between Grb2 and Gab248, both pro-
teins are identically associated in murine myeloid FDC-P1 cells treated or not with the colony-stimulating factor 
Figure 5. Interactome of Gab2 in Kit225 T-cells. (A) Venn diagram showing the overlap in proteins co-
immunoprecipitating with Gab2 in the two biological replicates performed. (B) Correlation between IL-2/Ctr 
SILAC ratios obtained in the two replicates analyzed. (C) Combined IL-2/Ctr SILAC ratio corresponding to 
all the proteins quantified in the two biological replicas of each Gab2 immunoprecipitation is represented as a 
function of protein intensity in the MS. Dots coloured in red represent proteins that are consistently enriched 
(IL-2/Ctr > 1.5; Significance B p-value < 0.0001). (D) Heat map and hierarchical clustering dendrogram 
indicating the IL-2/Ctr SILAC ratio measured in each replicate of the proteins associating with Gab2 upon IL-2 
stimulation.
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Figure 6. IL-2-inducible Gab2-interacting proteins. (A) Heat map and hierarchical clustering dendrogram 
indicating the SILAC IL-2/Ctr ratio displayed by the cytokine-inducible Gab2-binding protein in each replica. 
(B) Validation of selected well-known and novel Gab2-binding proteins by immunoblotting. (C) Relative 
binding abundance of the detected Gab2 interactors. *indicates described Gab2 interactors.
Figure 7. Gab2 phosphomap in IL-2-treated Kit225 T-lymphocytes. Schematic representation of Gab2 
structure indicating motifs, phosphosites and protein binding sites. IL-2-dependent and –independent 
phosphosites reported in this study are highlighted in red and black, respectively. *indicates that the 
phosphosite is not reported in PhosphoSitePlus database.
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(M-CSF)49. We provide substantial evidence indicating that the adaptor protein Grb2 is constitutively associated 
with Gab2 in CD4+ Kit225 T-lymphocytes. Consequently, as the binding does not depend on tyrosine phospho-
rylation, it could be postulated that Grb2 SH3 domain and Gab2 proline-rich domains are involved in the for-
mation of Grb2/Gab2 complex in Kit225 T-cells (Fig. 7). Noticeably, our previous study demonstrated that Grb2 
can be recruited to cytokine-induced pY375 on IL-2Rγ (manuscript in preparation). Thus, it seem plausible that 
upon IL-2 stimulation Grb2 and its constitutive interactor Gab2 are recruited to the activated receptor complex 
through the SH2 domains of Grb2.
It has been demonstrated that Grb2/Gab2 interaction can be disrupted as a consequence of Gab2 S210 and 
T391 phosphorylation and subsequent 14-3-3 protein recruitment27. We show that Gab2 pS210 and pT391 are 
not robustly induced in response to cytokine stimulation. In accordance, our Gab2 interactome study demon-
strates that 14-3-3 beta/alpha, which displayed a SILAC ratio of 1.4 (Supplementary Table S2), is not recruited to 
Gab2 in IL-2-treated T-lymphocytes. Moreover, we observe that Grb2/Gab2 interaction remains unaffected upon 
cytokine stimulation (Fig. 7). Overall, the integration of the quantitative proteomics and phosphoproteomics 
analyses indicate that this negative feedback mechanism is still not activated in Kit225 T-lymphocytes treated 
with IL-2 for 5 minutes.
Once assembled within the activated receptor complex, Gab2 is tyrosine phosphorylated in order to recruit 
downstream signaling molecules. Accordingly, our combinatorial Q-MS screen depicted several IL-2-triggered 
tyrosine phosphorylations in addition to numerous IL-2-inducible Gab2-interacting proteins. We demonstrate 
here that Gab2 Y476 and Y643 become phosphorylated in vivo upon 5 minutes treatment with IL-2 and provide 
substantial evidence indicating that the endogenous p85 regulatory subunit of PI3-kinase and tyrosine phos-
phatase PTPN11 associate with the scaffold protein in response to cytokine stimulation of T-lymphocytes. This is 
well in line with previous studies indicating that among others Gab2 pY476 and pY643 are involved in recruiting 
the p85 subunit of the PI3-kinase and the tyrosine phosphatase PTPN11, respectively39–40. Additionally, it has 
been reported that Gab2 pS210 inhibits the recruitment of the tyrosine phosphatase PTPN11 in response to 
growth factors50. As mentioned above, our study unveiled that Gab2 pS210 is not subjected to IL-2-mediated 
regulation after 5 minutes stimulation with the cytokine. These data suggest that the mechanisms disrupting the 
interaction between Gab2 and PTPN11 are not activated at early stages of IL-2 signal transduction.
Our investigation also resulted in the detection of three catalytic subunits of the Class IA PI3K fam-
ily (PIK3CA, PIK3CB and PIK3CD) as cytokine-induced Gab2-binding proteins. In an attempt to determine 
whether they are direct or indirect interactors of the scaffold protein we calculated their relative abundance within 
the complex. In comparison to the well-known direct Gab2 interaction partners PTPN11 and p85 PI3-kinase 
that were found to be the most prominent interactors of the scaffold protein upon IL-2 stimulation, the relative 
abundance of the three catalytic PI3K subunits was very low. Hence, we postulate that whereas PTPN11 and 
p85 associate directly with tyrosine phosphorylated Gab2, the catalytic PI3K subunits detected in this study are 
recruited to the scaffold protein indirectly via the p85 regulatory subunit.
The formation of Gab2/PTPN11 and Gab2/PI3K complexes leads to the activation of RAS/MAPK and PI3K/
AKT signaling branches, respectively. Both pathways are essential to assure IL-2-induced proliferation of Kit225 
T-lymphocytes as we demonstrated in our previous study20. MAPK and AKT serine/threonine kinases are the two 
core representatives of RAS/MAPK and PI3K/AKT pathways and both are known to phosphorylate a plethora of 
substrates. In addition to targeting downstream signaling molecules, both kinases also phosphorylate upstream 
effectors creating negative feedback mechanisms that are fundamental for the adequate orchestration of signal 
transduction. Arnaud and colleagues demonstrated that pre-treatment of T-cells with MEK and PI3K inhibitor 
decreased the characteristic shift of Gab2 in response to IL-2 suggesting that both signaling branches are involved 
in phosphorylating the scaffold protein Gab217. In fact, the study presented here uncovers the enormous impact 
IL-2 exerts on the serine/threonine phosphorylation status of Gab2. We found numerous site-specific Gab2 
phosphorylations, including previously non-reported ones, that were induced in response to IL-2 stimulation in 
T-lymphocytes.
Recently, Eulenfeld and co-workers have shown that MAPK-dependent phosphorylation on S551 in Gab1 is 
crucial for the recruitment of the scaffold protein to the plasma membrane and initiate a positive-feedback loop 
that results in enhanced MAPK activation51. This specific Gab1 residue is conserved in Gab2 and corresponds to 
S543. Strikingly, our SILAC-based quantitative phosphoproteomics screen shows that Gab2 pS543 is induced in 
vivo in Kit225 T-lymphocytes. Thus, it is likely that Gab2 pS543 is also involved in the membrane recruitment of 
Gab2 which allows the scaffold protein being in close proximity with signaling effectors that assure the propaga-
tion of signal transduction.
More importantly, this study reveals large number of Gab2 serine/threonine phosphorylations, including 
three novel phosphorylated serines, that are modulated upon IL-2 stimulation of CD4+ T-lymphocytes (Fig. 7). 
In addition, we also discovered and further validated that DLAT, ARID3A and ARID3B associate with Gab2 in 
response to cytokine stimulation in Kit225 T-cells. The overall regulation of Gab2-mediated signal transduction 
is determined by the crosstalk of phosphosites that ultimately orchestrate the protein recruitment/release balance. 
Consequently, this study provides a wealth of candidates for future hypothesis-driven mechanism-focused studies 
that may gain insights into the regulation and role of Gab2 in the signal propagation initiated by IL-2.
Methods
Cell culture and stimulation. The IL-2-dependent human T-cell line Kit22552 was maintained in RPMI 
1640 medium supplemented with 10% FBS, 1% Glutamax, 1% penicillin/streptomycin, 1% sodium pyruvate 
and 16 U/ml of recombinant human IL-2 (kindly provided by AIDS Research and Reference Reagent Program, 
Division of AIDS, NIH, USA) at a density of 1 × 106 cells/ml at 37 °C and 5% CO2. For SILAC experiments the 
RPMI media was custom-made and deficient for L-Arg, and L-Lys (Gibco-Invitrogen). It was supplemented with 
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glutamax, p/s and sodium pyruvate as mentioned before together with 10% dialyzed serum (Gibco-Invitrogen) 
and different versions of L-Lys (Lys0 or Lys4) and L-Arg (Arg0 or Arg6) from Cambridge Isotope Laboratories.
Prior stimulation Kit225 T-cells were IL-2-deprived for 48 h to arrest them at the G1 phase of the cell cycle and 
resemble resting T-cells. IL-2-dependent signaling networks were induced by adding 200 U of IL-2 to 50.106 cells/ml 
and incubating for 5 min at 37 °C. In SILAC experiments, Kit225 T-cells grown in light media (Arg0/Lys0) were 
kept unstimulated and served as control whereas cells grown in heavy media (Arg6/Lys4) were stimulated with 
the cytokine as described above. Treatment was quenched by keeping cells on ice for 5 min and rapidly washing 
them repeatedly with chilled PBS prior proceeding with cell lysis.
Human cervix epithelial adenocarcinoma HeLa cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM, Lonza) supplemented with 10% Fetal Bovine Serum, 1% Penicillin-Streptomycin and 1% L-Glutamine.
Protein extraction and immunoprecipitation. Kit225 T-cells were lysed with ice-cold co- 
immunopreicpitation buffer (25 mM TrisHCl pH 7.5, 100 mM NaCl, 1% NP-40, 1 mM sodium pervanadate, 
5 mM beta-glycerophosphate, 5 mM NaF, complete protease inhibitor cocktail (complete tablets, Roche)) and 
protein concentrations were estimated using BCA protein assay kit (Pierce).
In SILAC experiments protein lysates corresponding to untreated and IL-2-stimulated cells were combined in 
1:1 ratio according to their protein concentration whereas in non-SILAC experiments differentially treated cell 
conditions were processed separately. In both cases, cell lysates were pre-cleared for 1 h at 4 °C while magnetic 
beads coupled with protein G (ThermoFischer Scientific) were loaded with the antibody recognizing Gab2 by 
incubation at 4 °C. For immunoprecipitating Gab2 together with its corresponding binding partners, pre-cleared 
lysates were incubated with the magnetic beads coupled with the Gab2 antibody for 2 h at 4 °C in rotation. Then, 
immunoprecipitated proteins were washed 3 times with lysis buffer and eluted by 5 min boiling with loading 
buffer (50 mM Tris pH 6.8, 5% glycerol, 1.67% beta-mercaptoethanol, 1.67% SDS).
In-gel digestion and peptide extraction. Eluted immunecomplexes were run in two parallel lanes of a 
precast NuPAGE 4–12% Bis-Tris Gel (Invitrogen) and visualized with Colloidal Blue (Invitrogen). Both gel lanes 
were separately cut into slices and subjected to in-gel trypsinization (Promega) as previously described53. Briefly, 
gel slices were subjected to reduction with 10 mM DTT, alkylation by 55 mM chloroacetamide and protein diges-
tion by incubating with trypsin overnight at 37 °C.
Resulting tryptic peptides were extracted from the gel by serial incubations with 100% ACN and 30% ACN/3% 
TFA. Finally, the solutions obtained in all the incubations were pooled together and dried down in a vacuum cen-
trifuge. Whereas peptides derived from one of the lanes were directly concentrated and desalted using C18 stage 
tips (made in house using Empore disc –C18 Agilent Life Science) to further analyze by LC-MS/MS, peptides 
derived from the other lane were subjected to TiO2 enrichment prior to MS analysis.
Enrichment of phosphopeptides using TiO2 beads. Enrichment of phosphopeptides was performed 
as previously described53,54. 5 mm diameter titansphere beads (GL Sciences) were mixed with the equilibration 
buffer (50 mg/ml DHB in 80%ACN/1%TFA) 1:1 ratio (w/w) and incubated for 30 min at room temperature 
whereas vacuum-dried samples were adjusted to 60% ACN/1% TFA. 2 μl of equilibrated TiO2 slurry was added to 
the sample and incubated for 30 min at room temperature in with rotation for allowing phosphopeptides bind the 
beads. After brief centrifugation, supernatant was removed and TiO2 beads were transferred onto a home-made 
C8 Stage-Tip (Empore disc –C8 Agilent Life Science) where they were washed twice with 60% ACN/1% TFA. 
Phosphopeptides were eluted from the beads by two subsequent incubations using 5% NH4OH and 25% 
NH4OH/0.3% TFA. Finally, eluted phosphopeptides were dried down in a vacuum centrifuge and desalted using 
C18 stage tips prior LC-MS/MS analysis.
LC-MS/MS and data analysis. LC-MS/MS analysis of was carried out using a reverse phase liquid chro-
matography system (EASY-nLC 1000 ultra-high pressure, Thermo Fisher Scientific) interfaced with a Q Exactive 
mass spectrometer (Thermo Fischer Scientific) via a nanoelectrospray source (Thermo Fisher Scientific). 
Acidified peptides were loaded on an analytical in-house packed column (20 cm × 75 μm, ReproSil-Pur C18-AQ 
3 μm resin (Dr. Maisch GmbH)) in solvent A (0.5% acetic acid) and eluted by a nonlinear 120 min solvent B gradi-
ent (0.5% acetic acid, 80% ACN) at a flow rate of 250 nL/min. Q Exactive was operated in a top 10 data dependent 
mode. Survey scans were acquired at a resolution of 70,000 (m/z 400) and fragmentation spectra at 35,000 (m/z 
400). Precursors were fragmented by higher energy C-trap dissociation (HCD) with normalized collision energy 
of 25 eV. The maximum injection time was 120 ms for survey and 124 ms for MS/MS scan. Repeat sequencing of 
peptide was minimized by excluding the selected peptide candidates for 45 s.
All raw data files acquired were searched against the UniProt human database version 2014.01 (with 88,479 
sequence entries) with MaxQuant proteomics computational platform version 1.3.0.5 and using Andromeda 
search engine55. In SILAC experiments light and heavy labels were set as Arg0/Lys0 and Arg6/Lys4. Precursor and 
fragment mass tolerances were set to 7 and 20 ppm, respectively. Enzyme specificity was set to trypsin, allowing 
for cleavage N-terminal to proline and between aspartic acid and proline with a maximum of 2 missed cleav-
ages. Carbamidomethylation of cysteine (C) was set as fixed modification whereas oxidation of methionine (M), 
protein N-terminal acetylation, deamidation of asparagine and glutamine (NQ) and phosphorylation of serine/
threonine/tyrosine (STY) were selected as variable modifications for database searching. For peptide and protein 
identification a minimal peptide length of 7 amino acids was required and the false discovery rate was set at 0.01. 
Additionally, for protein identification we demanded at least two peptides, of which at least one was unique to the 
protein group. Both razor and unique peptides, except STY phosphorylated peptides were considered for protein 
quantification. For the analysis of phosphopeptides, 1% FDR, a minimum localization probability of 0.75 and a 
score difference of at least 5 was used56. Proteins with ratio IL-2/Ctr > 1.5; Significance B < 0.0001 were regarded 
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as significantly changing in the immunoprecipitated complexes following IL-2 treatment. In respect to phospho-
rylation changes, ratios IL-2/Ctr > 2 were considered as significant.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium57 via 
PRIDE partner repository with the dataset identifier PXD003286.
Bioinformatic analysis. Perseus statistical software was employed for the calculation of the statistical sig-
nificance B, a p-value that depends on protein intensities and ratios. It was also used to perform the heat map and 
hierarchical clustering analysis in which protein groups were clustered according to their ratios and following 
next settings: row and column distance calculated using the Euclidean algorithm; row and column linkage – 
average58. Phosphosites not reported in the PhosphoSitePlus database (http://www.phosphosite.org/homeAction.
action) were considered as novel. MS/MS spectra of the phosphorylated peptides bearing novel phosphosites of 
Gab2 were validated and annotated using MaxQuant viewer expert system59. Protein sequence alignment was 
performed by SIM (http://web.expasy.org/sim/) available in ExPASy Bioinformatics Resource Portal.
Western blot. Eluted immune complexes were resolved in precast gradient NuPAGE 4–12% Bis-Tris gels 
(Invitrogen) and transferred onto nitrocellulose membranes (Bio-Rad). Membranes were blocked with 2% BSA 
and incubated overnight at 4 °C with primary antibodies, including; Gab2 (sc-9313), SHP2 (sc-7844) and 14-3-3 
(sc-25276) from SantaCruz Biotechnology, ARID3A (A300-228 A) and ARID3B (A302-564 A) from Methyl 
Lab, GRB2 (610111, Transduction Lab), PI3 kinase p85 (#4257, Cell Signaling) and DLAT (ab126224, Abcam). 
Then, the membranes were repeatedly washed with TBST buffer (150 mM NaCl, 10 mM Tris, pH 8.0 and 0.1% 
Tween 20) and incubated with HRP-conjugated anti-rabbit (NA934, GE Healthcare), anti-mouse (NA931, GE 
Healthcare) or anti-goat (ref) secondary antibodies for 1 h at room temperature. Finally, the membranes were 
washed and processed with ECL solution (PRN2106, GE Healthcare) for detection scanning on a Kodak Image 
Station 1000. The intensity of the bands was quantified using ImageJ software (National Institutes of health, 
Bethesda, MD, USA).
RNA isolation and real-time qPCR for gene expression analyses. Total RNA was extracted from 
cells using TRIzol reagent (Invitrogen) following manufacturer’s instructions. 1 μg of RNA was then reverse tran-
scribed into cDNA by incubating with a reaction mixture containing 0.25 μg of random hexamers and 1 mM 
dNTP mix for 5 min at 65 °C followed by 1 h incubation at 37 °C with 1st Stand buffer (Invitrogen), 1 mM DTT and 
12 U of M-MLV reverse transcriptase (Promega). cDNA was amplified in the Strategene Mx2000P System using 
SYBR Green JumpStart Taq Ready Mix (Sigma-Aldrich) and quantified using Stratagene MxPro. Amplification of 
β -actin was used for normalization. Sequences of PCR primers are listed in Supplementary Table S1.
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